tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

BBIO Stock Latest News

BridgeBio Pharma Presents Updated Encouraging Clinical and Biomarker Data from its BBP-812 Canavan Disease Gene Therapy Program at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Press ReleasesBridgeBio Pharma Presents Updated Encouraging Clinical and Biomarker Data from its BBP-812 Canavan Disease Gene Therapy Program at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
17d ago
BBIO
BridgeBio Pharma to Present Updated Data from its BBP-812 Canavan Disease Gene Therapy Program at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Press ReleasesBridgeBio Pharma to Present Updated Data from its BBP-812 Canavan Disease Gene Therapy Program at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
24d ago
BBIO
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
28d ago
BBIO
BridgeBio Pharma Reports First Quarter 2023 Financial Results and Business Update
Press ReleasesBridgeBio Pharma Reports First Quarter 2023 Financial Results and Business Update
1M ago
BBIO
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference
Press ReleasesBridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference
1M ago
BBIO
BridgeBio initiated with an Outperform at Evercore ISI
The FlyBridgeBio initiated with an Outperform at Evercore ISI
2M ago
BBIO
BridgeBio price target raised to $27 from $25 at SVB Securities
The FlyBridgeBio price target raised to $27 from $25 at SVB Securities
2M ago
BBIO
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2M ago
BBIO
BridgeBio reports inducement grants under Nasdaq listing rule
The FlyBridgeBio reports inducement grants under Nasdaq listing rule
2M ago
BBIO
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2M ago
BBIO
UBS sees fair value for BridgeBio pipeline at $36-$40 per share
The FlyUBS sees fair value for BridgeBio pipeline at $36-$40 per share
2M ago
BBIO
Mizuho doubts BridgeBio selling itself, says royalty deal more likely
The FlyMizuho doubts BridgeBio selling itself, says royalty deal more likely
2M ago
BBIO
BridgeBio canceled conference over ‘conflict,’ Bloomberg reports
The FlyBridgeBio canceled conference over ‘conflict,’ Bloomberg reports
2M ago
BBIO
BridgeBio likely worth $3B-$4B in takeover, says BofA
The FlyBridgeBio likely worth $3B-$4B in takeover, says BofA
2M ago
BBIO
BridgeBio Pharma call volume above normal and directionally bullish
The FlyBridgeBio Pharma call volume above normal and directionally bullish
2M ago
BBIO
Here’s Why Investors Are Excited About BridgeBio (NASDAQ:BBIO) Stock
Market NewsHere’s Why Investors Are Excited About BridgeBio (NASDAQ:BBIO) Stock
2M ago
BBIO
BridgeBio attracting bigger companies’ takeover interest, Bloomberg says
The FlyBridgeBio attracting bigger companies’ takeover interest, Bloomberg says
3M ago
BBIO
BridgeBio attracting bigger companies’ takeover interest, Bloomberg says
The FlyBridgeBio attracting bigger companies’ takeover interest, Bloomberg says
3M ago
BBIO
BridgeBio announces first patient dosed in Phase 1 trial of BBP-398 with OPDIVO
The FlyBridgeBio announces first patient dosed in Phase 1 trial of BBP-398 with OPDIVO
3M ago
BMY
BBIO
BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1 Trial for SHP2 Inhibitor BBP-398 in Combination with Bristol Myers Squibb’s OPDIVO® (nivolumab)
Press ReleasesBridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1 Trial for SHP2 Inhibitor BBP-398 in Combination with Bristol Myers Squibb’s OPDIVO® (nivolumab)
3M ago
BBIO
BridgeBio Pharma Shares Preliminary Findings on Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I)
Press ReleasesBridgeBio Pharma Shares Preliminary Findings on Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I)
3M ago
BBIO
BridgeBio shares preliminary findings on glycosylated alpha-dystroglycan
The FlyBridgeBio shares preliminary findings on glycosylated alpha-dystroglycan
3M ago
BBIO